Skip to content

Effects of Mulligan Mobilization With Movement Versus Kinesiotaping and Placebo on Knee Function and Injury -Related Outcomes in Basketball Players

Effects of Mulligan Mobilization With Movement Versus Kinesiotaping and Placebo on Knee Function and Injury -Related Outcomes in Basketball Players: A Parallel -Group Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07510243
Acronym
Sport _MWM_RTC
Enrollment
60
Registered
2026-04-03
Start date
2025-01-06
Completion date
2026-02-27
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Injuries, Knee Injuries, Sport Injury

Keywords

Mulligan technique, kinesiotaping, Sports physiotherapy, randomized controlled trial, Mulligan technique, Kinesiotaping, Sports physiotherapy, randomized controlled, basketball players, sports injury

Brief summary

This is a randomized RTC study where the KOS-ADLS score of athletes' functionality and the OSTRC score of sports overuse injuries were used as outcomes, which were measured before the start of treatment, 1 hour and 2 weeks after treatment. In this study, 3 forms of intervention were used: Mulligan, Kinesiotaping and placebo in young basketball players with knee injuries.

Detailed description

Study type: Randomized Clinical Trial RTC ,with three intervention groups. Population: young basketball players. The intervention will last 2 weeks. Outcomes: KOS-ADLS; OSTRC. Statistical analysis: Mixed ANOVA

Interventions

OTHERMulligan Mobilization with movement MWM

Participants received the MWM technique in a squat position with a tibial glide by a physiotherapist certified in the mulligan concept twice a week for 2 weeks, the treatment lasted 5 minutes.

OTHERKinesiotaping

Participants received the same kinesiotaping pattern regardless of injury type twice a week for 2 weeks for 5 minutes.

OTHERPlacebo

Participants received a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks, lasting 5 minutes.

Sponsors

University Aleksander Moisiu Durres
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

This is a single blinded study as only the participants were masked, while the investigator, care provider, outcome assessors were not blinded. However, to reduce the risk of bias, standardized outcome and protocols were used.

Intervention model description

Participants are randomly assigned to one of three groups (mulligan, kinesiotaping and placebo.

Eligibility

Sex/Gender
ALL
Age
14 Years to 22 Years
Healthy volunteers
No

Inclusion criteria

Male and female basketball players Minimum of 2 years of sports experience Presence of knee injury Active participation in organized sports

Exclusion criteria

Previous knee surgery Knee instability Neurological disorders Refusal or contraindication to Mulligan mobilization

Design outcomes

Primary

MeasureTime frameDescription
KOS-SAS (ADLS)Baseline (Day 0), 1 hour after intervention, and 2 weeks after interventionThe Activities of Daily Living Scale (ADLS) subscale of the Knee Outcome Survey evaluates symptoms and functional limitations during daily activities. Scores range from 0 to 100, with higher scores indicating better function.

Secondary

MeasureTime frameDescription
Overuse Injury Questionnaire - Oslo Sports Trauma Research Center (OSTRC)Baseline (Day 0), 1 hour after intervention, and 2 weeks after interventionThe Oslo Sports Trauma Research Center (OSTRC) Overuse Injury Questionnaire is a validated self-report instrument used to monitor the severity and impact of overuse-related musculoskeletal problems. It evaluates the consequences of knee-related problems on sports participation, training volume, sports performance, and symptom severity. Responses to the four key questions are converted into a severity score ranging from 0 to 100, where higher scores indicate greater symptom severity and functional impairment.

Countries

Albania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026